GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » EPS without NRI

BetterLife Pharma (STU:NPAU) EPS without NRI : €-0.02 (TTM As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma EPS without NRI?

BetterLife Pharma's earnings per share without non-recurring items for the three months ended in Jan. 2024 was €-0.01. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2024 was €-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for BetterLife Pharma's EPS without NRI or its related term are showing as below:

STU:NPAU' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -349.5   Med: 22.3   Max: 51.6
Current: 51.6

STU:NPAU's 3-Year EPS without NRI Growth Rate is ranked better than
92.15% of 1299 companies
in the Biotechnology industry
Industry Median: 5.4 vs STU:NPAU: 51.60

BetterLife Pharma's EPS (Diluted) for the three months ended in Jan. 2024 was €-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was €-0.02.

BetterLife Pharma's EPS (Basic) for the three months ended in Jan. 2024 was €-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was €-0.02.


BetterLife Pharma EPS without NRI Historical Data

The historical data trend for BetterLife Pharma's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma EPS without NRI Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.44 -0.19 -0.11 -0.07 -0.02

BetterLife Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 -0.01 - -0.01

Competitive Comparison of BetterLife Pharma's EPS without NRI

For the Biotechnology subindustry, BetterLife Pharma's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's PE Ratio without NRI falls into.



BetterLife Pharma EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BetterLife Pharma  (STU:NPAU) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BetterLife Pharma EPS without NRI Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (STU:NPAU) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines